Head-to-head · WeighScore
Aurelius Health Group vs The Virtual NP
The verdict
Too close to call — both grade 60.8/100 (C).
Aurelius Health Group and The Virtual NP land on the same WeighScore, so neither clears the other on our six graded dimensions. Aurelius Health Group sits one line higher on the board (#311 vs #314) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Aurelius Health Group | The Virtual NP |
|---|---|---|
| WeighScore | 60.8/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #311 | #314 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | $199/mo (microdose tier, compounded) | Not disclosed |
| Coverage | Coverage not published | 7 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #311 · C
Strengths
- Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
- LegitScript Certified
- Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
- Unusually candid about the limited evidence base for microdosing
Where it loses points
- The advertised $89 is a first-month new-patient rate; every month after it is $199
- This is a 1 mg microdose programme and nothing else — no labelled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
- No state count is published, only 'most US states', confirmed at intake
- The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labelled 2.5-15 mg/week
- Compounded tirzepatide is not an FDA-approved finished product
Graded #314 · C
Strengths
- FDA-approved branded Zepbound and Wegovy only, no compounded
- Transparent fees: 99 visit or 75 per month membership
- HSA/FSA accepted and prior authorization assistance offered
- NP-led with same or next-day booking and home shipping
Where it loses points
- Branded only, so medication cost is high and billed separately
- Limited to seven states
- No compounded lower-cost GLP-1 alternative
- Single-provider practice may limit scale and hours
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.